Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. - Middleton O; Cosimo E; Dobbin E; McCaig AM; Clarke C; Brant AM; Leach MT; Michie AM; Wheadon H (Leukemia, 2015)